Similar Articles
3251 Type 2 dıabetes mellıtus and CA 19-9 levels
3252 Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C
3253 Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma
3254 Early steroid withdrawal after liver transplantation for hepatocellular carcinoma
3255 Acute pancreatitis and cholangitis: A complication caused by a migrated gastrostomy tube
3256 Portal vein thrombosis: Etiology and clinical outcome of cirrhosis and malignancy-related non-cirrhotic, non-tumoral extrahepatic portal venous obstruction
3257 Upper gastrointestinal bleeding from duodenal vascular ectasia in a patient with cirrhosis
3258 Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma
3259 Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
3260 Role of iron in hepatic fibrosis: One piece in the puzzle
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA